PainChek Director John Murray Retires After Decade on Board
Closing price · 2026-10-26: $0.073 · -6.41%
PainChek says non-executive director and former chair John Murray has retired with immediate effect after serving on the board for a decade. The company says its next priorities include expanding customer adoption and recurring revenue across its international markets; it reports more than 21 million pain assessments completed.